A citation-based method for searching scientific literature

Spyridon Deftereos, Georgios Giannopoulos, Christos Angelidis, Nikolaos Alexopoulos, Gerasimos Filippatos, Nikolaos Papoutsidakis, George Sianos, John Goudevenos, Dimitrios Alexopoulos, Vlasios Pyrgakis, Michael W Cleman, Antonis S Manolis, Dimitrios Tousoulis, John Lekakis. Circulation 2015
Times Cited: 140



Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink, Donald Latchem, Pieter Hoogslag, Anastazia Jerzewski, Peter Nierop, Alan Whelan, Randall Hendriks, Henk Swart, Jeroen Schaap, Aaf F M Kuijper, Maarten W J van Hessen, Pradyot Saklani, Isabel Tan, Angus G Thompson, Allison Morton, Chris Judkins, Willem A Bax, Maurits Dirksen, Marco Alings, Graeme J Hankey, Charley A Budgeon, Jan G P Tijssen, Jan H Cornel, Peter L Thompson. N Engl J Med 2020
Times Cited: 458




List of shared articles



Times cited

Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
Alessandro Andreis, Massimo Imazio, Francesco Piroli, Stefano Avondo, Matteo Casula, Elena Paneva, Gaetano Maria De Ferrari. Eur J Prev Cardiol 2022
10


COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study.
Justin Cole, Nay Htun, Robert Lew, Mark Freilich, Stephen Quinn, Jamie Layland. Cardiovasc Revasc Med 2022
2

Targeting the NLRP3 inflammasome in cardiovascular diseases.
Stefano Toldo, Eleonora Mezzaroma, Leo F Buckley, Nicola Potere, Marcello Di Nisio, Giuseppe Biondi-Zoccai, Benjamin W Van Tassell, Antonio Abbate. Pharmacol Ther 2022
9

Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Dhan B Shrestha, Pravash Budhathoki, YubRaj Sedhai, Manoj Khadka, Subashchandra Pokharel, Stuti Yadav, Toralben Patel, Islam Elgendy, Wasey Ali Yadullahi Mir, Nimesh K Patel. J Cardiovasc Pharmacol 2022
1

Colchicine in Cardiovascular Disease: In-Depth Review.
Spyridon G Deftereos, Frans J Beerkens, Binita Shah, George Giannopoulos, Dimitrios A Vrachatis, Sotiria G Giotaki, Gerasimos Siasos, Johny Nicolas, Clare Arnott, Sanjay Patel,[...]. Circulation 2022
6

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
Fan-Shun Zhang, Qing-Ze He, Chengxue Helena Qin, Peter J Little, Jian-Ping Weng, Suo-Wen Xu. Acta Pharmacol Sin 2022
4


Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial.
He Zhang, Xikun Han, Tuo Pan, Hai-Tao Zhang, Kai Zhong, Ze-Shi Li, Xinyi Jiang, Jun Pan, Dong-Jin Wang. BMJ Open 2022
0

Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
Yi Chen, Hongzhou Zhang, Yuxin Chen, Meng Li, Wei Luo, Yue Liu, Yang Fu, Huasong Xia, Cong Xu, Yu Jiang,[...]. Clin Rheumatol 2022
0

Myocardial ischemia-reperfusion injury and the influence of inflammation.
M Algoet, S Janssens, U Himmelreich, W Gsell, M Pusovnik, J Van den Eynde, W Oosterlinck. Trends Cardiovasc Med 2022
5


Effect of colchicine on inflammatory markers in patients with coronary artery disease: A meta-analysis of clinical trials.
Zimo Pan, Jiayu Cheng, Wenjia Yang, Lingxia Chen, Jingtong Wang. Eur J Pharmacol 2022
0

Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
Song Shen, Junfeng Duan, Jiaxin Hu, Yu Qi, Lina Kang, Kun Wang, Jianzhou Chen, Xiang Wu, Biao Xu, Rong Gu. Eur J Pharmacol 2022
0

Colchicine for Coronary Artery Disease: A Review.
Tao Chen, Guihong Liu, Bo Yu. Front Cardiovasc Med 2022
0

Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
Matteo Casula, Alessandro Andreis, Stefano Avondo, Matteo Pio Vaira, Massimo Imazio. Future Cardiol 2022
0

Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation.
Ulrike Meyer-Lindemann, Carina Mauersberger, Anna-Christina Schmidt, Aldo Moggio, Julia Hinterdobler, Xinghai Li, David Khangholi, Jan Hettwer, Christian Gräßer, Alexander Dutsch,[...]. Front Immunol 2022
0

The Role of Colchicine in Atherosclerosis: From Bench to Bedside.
Leticia González, Juan Francisco Bulnes, María Paz Orellana, Paula Muñoz Venturelli, Gonzalo Martínez Rodriguez. Pharmaceutics 2022
0

Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
JingWen Yong, JinFan Tian, WenJian Jiang, Xin Zhao, HongJia Zhang, XianTao Song. Clin Ther 2022
0

Colchicine for the treatment of coronary artery disease.
Alberto Aimo, Domingo A Pascual-Figal, Andrea Barison, Germán Cediel, Álvaro Hernández Vicente, Luigi F Saccaro, Michele Emdin, Antoni Bayes-Genis. Trends Cardiovasc Med 2021
6

Giving Drugs a Second Chance.
Pooja M Swamy, Mamas A Mamas. Cardiovasc Revasc Med 2021
0

Updating concepts on atherosclerotic inflammation: From pathophysiology to treatment.
Stefano Ministrini, Federico Carbone, Fabrizio Montecucco. Eur J Clin Invest 2021
10

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
Subuhi Kaul, Manasvi Gupta, Dhrubajyoti Bandyopadhyay, Adrija Hajra, Prakash Deedwania, Edward Roddy, Mamas Mamas, Allan Klein, Carl J Lavie, Gregg C Fonarow,[...]. Am J Cardiovasc Drugs 2021
5

Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics.
Shereif H Rezkalla, Robert A Kloner. Trends Cardiovasc Med 2021
16

Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
Zujin Xiang, Jian Yang, Jun Yang, Jing Zhang, Zhixing Fan, Chaojun Yang, Liu Di, Cong Ma, Jingyi Wu, Yifan Huang. Intern Emerg Med 2021
4

Colchicine Use in Acute Coronary Syndromes: An Update.
Laura Tapoi, Laura Benchea, Dimitrie Siriopol, Mehmet Kanbay, Adrian Covic. Angiology 2021
0

Colchicine efficacy and safety for the treatment of cardiovascular diseases.
Alessandro Andreis, Massimo Imazio, Matteo Casula, Stefano Avondo, Gaetano Maria De Ferrari. Intern Emerg Med 2021
4

Colchicine in ischemic heart disease: the good, the bad and the ugly.
Domenico D'Amario, Donato Cappetta, Luigi Cappannoli, Giuseppe Princi, Stefano Migliaro, Giovanni Diana, Karim Chouchane, Josip A Borovac, Attilio Restivo, Alessandra Arcudi,[...]. Clin Res Cardiol 2021
9


Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.
Sofia Nolasco, Javier Bellido, Marina Serna, Bruno Carmona, Helena Soares, Juan Carlos Zabala. Front Cell Dev Biol 2021
5

Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Justin Cole, Nay Htun, Robert Lew, Mark Freilich, Stephen Quinn, Jamie Layland. Circ Cardiovasc Interv 2021
9


Inflammation during Percutaneous Coronary Intervention-Prognostic Value, Mechanisms and Therapeutic Targets.
Bradley Tucker, Kaivan Vaidya, Blake J Cochran, Sanjay Patel. Cells 2021
2

Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
Nadia Bouabdallaoui, Jean-Claude Tardif. Curr Cardiol Rep 2021
0

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
Thomas Kofler, Reto Kurmann, Dirk Lehnick, Giacomo Maria Cioffi, Sujay Chandran, Adrian Attinger-Toller, Stefan Toggweiler, Richard Kobza, Federico Moccetti, Florim Cuculi,[...]. J Am Heart Assoc 2021
10

Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
Guillaume Marquis-Gravel, Shaun G Goodman, Todd J Anderson, Alan D Bell, David Bewick, Jafna Cox, Jean C Grégoire, Anil Gupta, Thao Huynh, Heather Kertland,[...]. Can J Cardiol 2021
3

Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
Nathan Mewton, François Roubille, Didier Bresson, Cyril Prieur, Claire Bouleti, Thomas Bochaton, Fabrice Ivanes, Olivier Dubreuil, Loïc Biere, Ahmad Hayek,[...]. Circulation 2021
19

Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.
Li Wang, Yunfan Peng, Lijun Song, Dasheng Xia, Chao Li, Zhuqing Li, Qi Li, Ao Yu, Chengzhi Lu, Yongjian Wang. Cardiovasc Drugs Ther 2021
4

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
Tjerk S J Opstal, Aernoud T L Fiolet, Amber van Broekhoven, Arend Mosterd, John W Eikelboom, Stefan M Nidorf, Peter L Thompson, Michiel Duyvendak, J W Martijn van Eck, Eugène A van Beek,[...]. J Am Coll Cardiol 2021
5

Inflammation and ischemic heart disease: The next therapeutic target?
Eduardo M Vilela, Ricardo Fontes-Carvalho. Rev Port Cardiol (Engl Ed) 2021
1

Inflammation and ischemic heart disease: The next therapeutic target?
Eduardo M Vilela, Ricardo Fontes-Carvalho. Rev Port Cardiol (Engl Ed) 2021
2

Network Pharmacology-Based Investigation and Experimental Exploration of the Antiapoptotic Mechanism of Colchicine on Myocardial Ischemia Reperfusion Injury.
Yuanjun Tang, Chenyang Shi, Yingyi Qin, Shuowen Wang, Hui Pan, Ming Chen, Xuemei Yu, Yuefen Lou, Guorong Fan. Front Pharmacol 2021
2